The two COVID-19 vaccines being distributed across the US are special not only because of the focus and cooperation required to get them into clinics quickly, but because they represent a new class of medicine: the first approved drugs of any kind based on mRNA. Where traditional vaccines use inactive viruses, the new vaccines deliver protein-building instructions that help train the immune system to fight the actual virus. But getting the mRNA into the cell is a whole other challenge. Watch the